• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • Breast cancer
  • News

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Health news

an independent service from the Current Medicine Group

  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next

Date

    • Jul 7, 2009
    • Letrozole and tamoxifen differentially affect plasma hormones   Clinical trial results show that postmenopausal women with early breast cancer have different hormonal responses to letrozole compared with tamoxifen treatment.
    • Jul 6, 2009
    • Genomic grade index predicts chemotherapy response in breast cancer patients   Genomic grade index is associated with increased response to neoadjuvant chemotherapy in breast cancer patients irrespective of estrogen receptor (ER) status, study results show.
    • Jun 30, 2009
    • Selenium may worsen prostate cancer in some men   High levels of selenium in the blood may worsen prostate cancer in some men who already have the disease, results of a US study suggest.
    • Jun 30, 2009
    • Occult tumor cells linked to lobular breast cancer type   French researchers have found that the spread of occult tumor cells in small invasive breast cancers may be associated with a lobular histology, but is independent of classical tumor histologic factors.
    • Jun 30, 2009
    • Mammograms being missed after DCIS surgery   US researchers highlight the importance of regular mammograms in women treated for dual carcinoma
    • Jun 29, 2009
    • Age does not influence recurrence risk in early breast cancer patients   Young women with an early type of breast cancer called ductal carcinoma
    • Jun 29, 2009
    • ER-positive/PR-negative breast cancer linked to carbohydrate intake   Researchers have found evidence of a link between risk for estrogen receptor-positive and progesterone receptor-negative breast cancer and carbohydrate intake.
    • Jun 26, 2009
    • Further evidence for hormone therapy link to breast cancer   The recent decline in the number of women diagnosed with invasive breast cancer in the USA is much more pronounced in wealthy urban areas than in poor and rural areas, which reflects differences in the use of hormone replacement therapy and access to information regarding the risk of breast cancer, say US researchers.
    • Jun 26, 2009
    • US breast cancer reduction patterns attributed to hormone therapy use   Discrepancies in the rates of breast cancer between urban and rural US populations may be due to differences in their pattern of hormone therapy use, researchers believe.
    • Jun 26, 2009
    • Patient support improves breast cancer treatment adherence   Increasing support for patients undergoing breast cancer treatment can help improve adherence to treatment, study findings suggest.
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009